The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α

Author:

Orr James G.12,Currie Craig J.34,Berni Ellen4,Goel Anurag5,Moriarty Kieran J.5,Sinha Ashish6,Gordon Fiona6,Dethier Anne7,Dillon John F.7,Clark Katie8,Richardson Paul8,Middleton Paul9,Patel Vishal9,Shawcross Debbie9,Preedy Helen10,Aspinall Richard J.10,Hudson Mark12

Affiliation:

1. Liver Unit; Freeman Hospital; Newcastle upon Tyne UK

2. Institute of Cellular Medicine; Newcastle University; Newcastle upon Tyne UK

3. Cochrane Institute; School of Medicine; Cardiff University; Cardiff UK

4. Pharmatelligence; Cardiff UK

5. Gastroenterology; Royal Bolton Hospital; Bolton UK

6. Liver Unit; Bristol Royal Infirmary; Bristol UK

7. Gastroenterology; Ninewells Hospital; Dundee UK

8. Gastroenterology; The Royal Liverpool University Hospital; Liverpool UK

9. Institute of Liver Studies and Transplantation; King's College London School of Medicine; King's College Hospital; London UK

10. Gastroenterology and Hepatology; Queen Alexandra Hospital; Portsmouth UK

Funder

National Institute for Health Research

Newcastle upon Tyne Hospitals NHS Foundation Trust

Newcastle University

Publisher

Wiley

Subject

Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3